Skip to content

A study comparing two forms of calendula officinalis where one form is given as mother tincture both internally and externally whereas the other form 30 C potency is given internally along with mother tincture externally in the treatment of bedsores in adults

A comparative evaluation of the therapeutic effectiveness of Calendula Officinalis administered internally and externally as mother tincture versus Calendula 30C with Calendula mother tincture externally in adult age group in management of bedsore - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104534
Enrollment
68
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L89- Pressure ulcer

Interventions

Intervention1: Calendula Officinalis: Homoeopathic medicine Calendula Officinalis in Mother tincture form will be administered per orally 5ml internally as well as externally to bedsore The dose wi

Sponsors

Saqib Ahmad Iqbal Ahmad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i Patients of both sexes of adult age diagnosed with bedsores ii Patients from different occupations religion socioeconomic status and those residing in urban field & rural field will get consider in study iii Participants who are willing for giving informed consent

Exclusion criteria

Exclusion criteria: i Patients diagnosed with any serious medical conditions unconscious patient ,patient with septicaemia, septic shock ,Abscess, cellulitis,osteomyelitis, severe burns ,patient with stage 4 bedsores and comorbidities will be excluded ii Immunocompromised patients will be excluded from the study iii Patients who refuse to give informed consent will be excluded from the study iv People or subject belonging to age group other than adult age will be excluded

Design outcomes

Primary

MeasureTime frame
Treatment efficacy and the quality of lifeTimepoint: 2 weeks

Secondary

MeasureTime frame
Treatment efficacy & the quality of lifeTimepoint: 4 weeks

Countries

India

Contacts

Public ContactSaqib Ahmad Iqbal Ahmad

Guru mishri homoeopathic medical college and hospital

pg@gurumishrihmc.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026